(Q27649827)

1

0 references

Zhulun Wang

2

0 references

Noboru Furukawa

3

0 references

Patrick Escaron

4

0 references

Jennifer Weiszmann

5

0 references

Gary Lee

6

0 references

Michelle Lindstrom

7

0 references

Jinsong Liu

8

0 references

Xiaohong Liu

9

0 references

Haoda Xu

10

0 references

Olga Plotnikova

11

0 references

Vidya Prasad

12

0 references

Nigel Walker

13

0 references

R Marc Learned

14

0 references

Jin-Long Chen

Journal of Biological Chemistry

15

0 references

language of work or name

English

0 references

publication date

4 April 2008

0 references

published in

0 references

volume

283

0 references

issue

14

0 references

page(s)

9168-76

0 references

cites work

PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

A unified nomenclature system for the nuclear receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

PPARs and the complex journey to obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

PPAR gamma and human metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

The organization, promoter analysis, and expression of the human PPARgamma gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

PPAR(gamma) and glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

Peroxisome proliferator-activated receptor-gamma calls for activation in moderation: lessons from genetics and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

Phenotypic consequences of the peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism: the weight of the evidence in genetic association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

Processing of X-ray diffraction data collected in oscillation mode

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

The CCP4 suite: programs for protein crystallography

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

Going nuclear in metabolic and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

Aspects of the regulatory mechanisms of PPAR functions: analysis of a bidirectional response element and regulation by sumoylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

SUMOylation and PPARgamma: wrestling with inflammatory signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800104200

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1038/47254